Ascending Doses of Autologous FDP vs FFP

Phase 1 Completed 30 enrolled U.S. Army Medical Research and Development Command

RandomizedParallel-groupTriple-blindTreatment

Assess the safety of single infusions with RePlas FDP product at increasing fixed doses

Evaluation	Drug	Modality	Dose	Route
Subject	Autologous Freeze Dried Plasma	Protein / enzyme biologic	270 ml	Other
Subject	Autologous Freeze Dried Plasma	Protein / enzyme biologic	540 ml	Other
Subject	Autologous Freeze Dried Plasma	Protein / enzyme biologic	810 ml	Other
Comparator	Fresh Frozen Plasma	Protein / enzyme biologic	810 ml	Other

No indication recorded.